London · Delayed Price · Currency is GBP · Price in USD VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of GBP 4.29 million. The enterprise value is -1.89 million.
| Market Cap | 4.29M |
| Enterprise Value | -1.89M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +101.37% |
| Shares Change (QoQ) | +53.96% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 5.47% |
| Float | 2.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.42 |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.30 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.25 |
Financial Position
The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.09.
| Current Ratio | 4.52 |
| Quick Ratio | 4.24 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -867.47 |
Financial Efficiency
Return on equity (ROE) is -24.53% and return on invested capital (ROIC) is -82.93%.
| Return on Equity (ROE) | -24.53% |
| Return on Assets (ROA) | -70.78% |
| Return on Invested Capital (ROIC) | -82.93% |
| Return on Capital Employed (ROCE) | -123.48% |
| Revenue Per Employee | 7,973 |
| Profits Per Employee | -111,562 |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.86% in the last 52 weeks. The beta is 1.13, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -74.86% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 10.99 |
| Relative Strength Index (RSI) | 38.65 |
| Average Volume (20 Days) | 9,214 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.23 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of GBP 103,646 and -1.45 million in losses. Loss per share was -0.81.
| Revenue | 103,646 |
| Gross Profit | -3.56M |
| Operating Income | -8.86M |
| Pretax Income | -1.45M |
| Net Income | -1.45M |
| EBITDA | -8.68M |
| EBIT | -8.86M |
| Loss Per Share | -0.81 |
Balance Sheet
The company has 6.61 million in cash and 599,978 in debt, giving a net cash position of 6.01 million.
| Cash & Cash Equivalents | 6.61M |
| Total Debt | 599,978 |
| Net Cash | 6.01M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.96M |
| Book Value Per Share | 2.68 |
| Working Capital | 5.50M |
Cash Flow
In the last 12 months, operating cash flow was -7.60 million and capital expenditures -9,489, giving a free cash flow of -7.61 million.
| Operating Cash Flow | -7.60M |
| Capital Expenditures | -9,489 |
| Free Cash Flow | -7.61M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -8,552.80% |
| Pretax Margin | -1,399.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -101.37% |
| Shareholder Yield | -101.37% |
| Earnings Yield | -33.78% |
| FCF Yield | -177.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 19, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Aug 19, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
VivoSim Labs has an Altman Z-Score of -41.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -41.31 |
| Piotroski F-Score | 3 |